Long-term medical comorbidities and their management: hypertension/cardiovascular disease.

Liver Transpl

Department of General, Visceral, and Transplantation Surgery, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Published: November 2009

1. There is a high prevalence of cardiovascular risk factors in liver transplant recipients. 2. There is a high incidence of premature onset of cardiovascular disease. 3. The choice of calcineurin inhibitor shows no long-term impact. 4. Established cardiovascular risk scores may determine an individual's risk for cardiovascular events. 5. Posttransplant arterial hypertension is a major burden. 6. Strict surveillance guidelines are needed. 7. Threshold levels for arterial blood pressure according to recommendations for high-risk individuals should be applied. 8. Therapeutic lifestyle changes should be encouraged. 9. Escalating pharmacological treatment with respect to renal function is recommended. 10. Alterations of immunosuppression should be considered.

Download full-text PDF

Source
http://dx.doi.org/10.1002/lt.21903DOI Listing

Publication Analysis

Top Keywords

cardiovascular risk
8
long-term medical
4
medical comorbidities
4
comorbidities management
4
management hypertension/cardiovascular
4
hypertension/cardiovascular disease
4
disease high
4
high prevalence
4
cardiovascular
4
prevalence cardiovascular
4

Similar Publications

Background And Objectives: Lipid metabolism in older adults is affected by various factors including biological aging, functional decline, reduced physiologic reserve, and nutrient intake. The dysregulation of lipid metabolism could adversely affect brain health. This study investigated the association between year-to-year intraindividual lipid variability and subsequent risk of cognitive decline and dementia in community-dwelling older adults.

View Article and Find Full Text PDF

Background: There is still a significant population of patients with embolic stroke of Undetermined Source (ESUS) whose specific attributable cause of the stroke remains unknown.

Objectives: Our research aimed to assess clinical, electrocardiogram, laboratory, and echocardiographic parameters that may predict the propensity of paroxysmal atrial fibrillation (PAF).

Methods: We enrolled seventy-five ESUS patients who were in sinus rhythm at the time of stroke diagnosis to undergo in-hospital 7-day Holter monitoring, testing for Pro-BNP, and a standard echocardiographic examination.

View Article and Find Full Text PDF

CARDIOVASCULAR RISK BEFORE AND AFTER SURGICAL TREATMENT OF SEVERE OBESITY.

Arq Bras Cir Dig

January 2025

Universidade de São Paulo, Faculty of Medicine, Department of Gastroenterology - São Paulo (SP), Brazil.

Background: Obesity is a predisposing factor for serious comorbidities, particularly those related to elevated cardiovascular mortality. The atherogenic index of plasma (AIP) has been shown to be a useful indicator of patients with insulin resistance.

Aims: The aim of this study was to assess cardiovascular risk before and after surgical treatment of obesity.

View Article and Find Full Text PDF

A systematic review on the influence of coagulopathy and immune activation on New Onset Atrial Fibrillation in patients with sepsis.

PLoS One

January 2025

Department of Cardiovascular and Metabolic Medicine, Faculty of Health and Life Sciences, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom.

Introduction: New Onset Atrial Fibrillation (NOAF) is the most common arrhythmia in intensive care. Complications of NOAF include thromboembolic events such as myocardial infarction and stroke, which contribute to a greater risk of mortality. Inflammatory and coagulation biomarkers in sepsis are thought to be associated with NOAF development.

View Article and Find Full Text PDF

Importance: A comprehensive lipid panel is recommended by guidelines to evaluate atherosclerotic cardiovascular disease risk, but uptake is low.

Objective: To evaluate whether direct outreach including bulk orders with and without text messaging increases lipid screening rates.

Design, Setting, And Participants: Pragmatic randomized clinical trial conducted from June 6, 2023, to September 6, 2023, at 2 primary care practices at an academic health system among patients aged 20 to 75 years with at least 1 primary care visit in the past 3 years who were overdue for lipid screening.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!